New Delhi, April 8 Zydus Lifesciences Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, indicated for controlling blood sugar in adults with type 2 diabetes mellitus.The approval from the US Food and...
ahmedabad
blood sugar control
dapagliflozin
diabetes mellitus
generic drugs
pharmaceuticals
tablet formulation
type 2 diabetes
united states
usfda
zydus lifesciences
New Delhi, April 8 Biocon Ltd announced on Wednesday that its subsidiary, Biocon Pharma Ltd, has received approval from the US health regulator for its genetically engineered version of dapagliflozin tablets, indicated for reducing blood sugar levels in adults with type 2 diabetes mellitus.The...
New Delhi, April 7 Aurobindo Pharma announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, which are used to control blood sugar levels in people with type 2 diabetes.The final approval granted by the US Food &...
New Delhi, April 7 Alembic Pharmaceuticals Ltd announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, used to control blood sugar levels in people with type-2 diabetes.The approval from the US Food & Drug...